These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1822317)

  • 1. Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.
    Senin U; Abate G; Fieschi C; Gori G; Guala A; Marini G; Villardita C; Parnetti L
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):511-7. PubMed ID: 1822317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent.
    Sourander LB; Portin R; Mölsä P; Lahdes A; Rinne UK
    Psychopharmacology (Berl); 1987; 91(1):90-5. PubMed ID: 3103163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.
    Lee CR; Benfield P
    Drugs Aging; 1994 Mar; 4(3):257-73. PubMed ID: 8199398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and tolerance of aniracetam in elderly patients with primary or secondary mental deterioration].
    Canonico V; Forgione L; Paoletti C; Casini A; Colonna CV; Bertini M; Acito R; Rengo F
    Riv Neurol; 1991; 61(3):92-6. PubMed ID: 1767242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial.
    Burke WJ; Roccaforte WH; Wengel SP; Bayer BL; Ranno AE; Willcockson NK
    J Am Geriatr Soc; 1993 Nov; 41(11):1219-25. PubMed ID: 8227897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type.
    Parnetti L; Abate G; Bartorelli L; Cucinotta D; Cuzzupoli M; Maggioni M; Villardita C; Senin U
    Drugs Aging; 1993; 3(2):159-64. PubMed ID: 8477148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.
    Weyer G; Babej-Dölle RM; Hadler D; Hofmann S; Herrmann WM
    Neuropsychobiology; 1997; 36(2):73-82. PubMed ID: 9267856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).
    Rüther E; Ritter R; Apecechea M; Freytag S; Windisch M
    Pharmacopsychiatry; 1994 Jan; 27(1):32-40. PubMed ID: 8159781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of BMY 21,502 in Alzheimer disease.
    Shrotriya RC; Cutler NR; Sramek JJ; Veroff AE; Hironaka DY
    Ann Pharmacother; 1996 Dec; 30(12):1376-80. PubMed ID: 8968446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease.
    Cutler NR; Shrotriya RC; Sramek JJ; Veroff AE; Seifert RD; Reich LA; Hironaka DY
    Ann N Y Acad Sci; 1993 Sep; 695():332-6. PubMed ID: 8239308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results.
    Burke WJ; Ranno AE; Roccaforte WH; Wengel SP; Bayer BL; Willcockson NK
    J Am Geriatr Soc; 1993 Apr; 41(4):367-70. PubMed ID: 8463521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
    Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
    Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
    Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
    Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests.
    Somnier FE; Ostergaard MS; Boysen G; Bruhn P; Mikkelsen BO
    Psychopharmacology (Berl); 1990; 101(1):43-6. PubMed ID: 2188276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups.
    Bentham PW
    Int Clin Psychopharmacol; 1990 Oct; 5(4):261-72. PubMed ID: 2081897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.